Search | IOVS | ARVO Journals

Showing 1 – 20 of 33

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Disease Activity Assessments with Brolucizumab vs Aflibercept in Patients with nAMD in HAWK and HARRIER

Rishi P Singh; Robin Hamilton; Jeffrey S Heier; Carl Regillo; Mark C Gillies; Georges Weissgerber; Jahangir Alam; Pravin U Dugel

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1158. doi:

ARVO Annual Meeting Abstract June 2020

Anatomic and visual outcomes of primary retinal detachment in younger adults: a report from the multicenter Primary Retinal Detachment Outcomes (PRO) Study

Louis Cai; Michael J Ammar; Ed Ryan; Jay Wang; Claire Ryan; Connie M Wu; Matthew Starr; Luv Patel; Antonio Capone; Dean Eliott; Geoffrey Emerson; Daniel Joseph; Omesh Gupta; Carl Regillo; Yoshihiro Yonekawa

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3710. doi:

ARVO Annual Meeting Abstract June 2020

Retinal Detachment Rates and Clinical Outcomes Following Penetrating and Endothelial Keratoplasty

Durga Borkar; Hannah Levin; Turner David Wibbelsman; Sara Rapuano; Daniel MacKinnon; Allen C Ho; Jason Hsu; Carl Regillo; Brandon Ayres; Kristin Hammersmith; Parveen Nagra; Irving Raber; Christopher Rapuano; Zeba Syed

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3761. doi:

ARVO Annual Meeting Abstract June 2020

Characteristics of Clinical Studies Evaluating Off-Label Indications for Novel FDA-Approved Therapeutics in Ophthalmology

Anand Gopal; Joshua Wallach; Saloni Shah; Carl Regillo; Joseph Ross

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3070. doi:

ARVO Annual Meeting Abstract July 2019

Ocular hypertension following intravitreal injection of 0.7mg dexamethasone implant versus 2mg triamcinolone

Brandon Kuley; Philip Storey; Maitri Pancholy; Anthony Obeid; James Murphy; Jake Goodman; Turner D Wibbelsman; Carl Regillo; Allen Chiang

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2645. doi:

ARVO Annual Meeting Abstract July 2019

Clinical outcomes after switch from aflibercept to ranibizumab for macular edema secondary to retinal vein occlusion

Turner D Wibbelsman; Daniel B Calem; Anthony Obeid; Phoebe L Mellen; Michelle A. Konkoly; Michael R. Velez; Kareem Sioufi; Durga S Borkar; Ravi Pandit; Michael A. Klufas; Jason Hsu; Carl Regillo; Allen C Ho; Omesh P Gupta; Marc J. Spirn

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4057. doi:

ARVO Annual Meeting Abstract July 2019

Short-Term Outcomes of Eyes with Neovascular Age-related Macular Degeneration (nAMD) that Switched from Aflibercept to Ranibizumab

Jason Hsu; Anthony Obeid; Phoebe L Mellen; Turner D Wibbelsman; Michelle A. Konkoly; Michael R. Velez; Daniel B. Calem; Kareem Sioufi; Daniel Su; Philip Storey; Michael A. Klufas; Marc J. Spirn; Carl Regillo; Allen C Ho

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):80. doi:

ARVO Annual Meeting Abstract July 2018

Incidence of ocular hypertension following intravitreal injection of 2mg triamcinolone

Philip Storey; Anthony Obeid; Maitri Pancholy; Jake Goodman; Xinxiao Gao; Durga S Borkar; Daniel Su; Carl Regillo

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):79. doi:

ARVO Annual Meeting Abstract July 2018

Baseline Choroidal Thickness as a Predictor for Treatment Outcomes in Branch Retinal Vein Occlusion

Nadim Rayess; Ehsan Rahimy; Gui-Shuang Ying; Maria Pefkianaki; Carl Regillo; allen ho; Jason Hsu

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4291. doi:

ARVO Annual Meeting Abstract July 2018

Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Transplantation for Retinal Degenerations: Three-Year Outcomes Data

Steven D Schwartz; Carl Regillo; Byron L Lam; Dean Eliott; Ninel Gregori; Jean-Pierre Hubschman; Gad Heilweil; Marc Spirn; Joseph Maguire; Rosaleen Ostrick; Lucian Del Priore; Eddy Anglade; Robert Lanza

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5004. doi:

ARVO Annual Meeting Abstract June 2017

Effect of Hydroxychloroquine Exposure and Toxicity on Dark Adaptation

Charles Affel; Maria Pefkianaki; Priya Sharma; Allen Ho; Jason Hsu; Joseph Maguire; Carl D Regillo; Elizabeth Affel; Julia A Haller

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):225. doi:

ARVO Annual Meeting Abstract June 2017

27-gauge vitrectomy wound integrity: a randomized pilot study comparing angled versus straight entry in fluid-filled vitrectomized eyes

M. Ali Ali Khan; Alia Durrani; Jason Hsu; Carl D Regillo

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2791. doi:

ARVO Annual Meeting Abstract June 2017

Optical Coherence Tomography Angiography in Hydroxychloroquine Toxicity

Priya Sharma; Maria Pefkianaki; Murtaza K Adam; Allen Ho; Jason Hsu; Joseph Maguire; Carl D Regillo; Charles G. Affel; Elizabeth Affel; Julia A Haller

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3682. doi:

ARVO Annual Meeting Abstract June 2017

Comparison of chandelier-assisted scleral buckling versus traditional scleral buckling for rhegmatogenous retinal detachment repair at an academic teaching center

Katherine E Talcott; Anthony Obeid; Allen Chiang; Sunir Garg; Allen Ho; Carl D Regillo; Jason Hsu

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4154. doi:

ARVO Annual Meeting Abstract September 2016

Conversion to aflibercept after prior anti-VEGF therapy for persistent diabetic macular edema

Ehsan Rahimy; Abtin Shahlaee; M. Ali Khan; Gui-Shuang Ying; Joseph Maguire; Allen Ho; Carl D Regillo; Jason Hsu

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2071. doi:

ARVO Annual Meeting Abstract September 2016

Sustained Delivery of Ranibizumab: The LADDER Trial of the Ranibizumab Port Delivery System

J Jill Hopkins; Carl D Regillo; Aaron Osborne; Steven F Francom; Giulio Barteselli

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):530. doi:

ARVO Annual Meeting Abstract September 2016

Pharmacologic Closure Rate of Full Thickness Macular Hole with Ocriplasmin—1 year follow-up data

Priya Sharma; Ehsan Rahimy; Carl D Regillo

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4046. doi:

ARVO Annual Meeting Abstract September 2016

Prospective, Multicenter Investigation of Aflibercept Treat and Extend Therapy for Neovascular Age-related Macular Degeneration (ATLAS Study): One and Two Year Results

Francis Char DeCroos; David Carleton Reed; Murtaza K Adam; David A Salz; Omesh Gupta; Allen C Ho; Carl D Regillo

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi:

ARVO Annual Meeting Abstract June 2015

Economic Evaluation of Home Telemonitoring for CNV

John Wittenborn; Traci E Clemons; Carl D Regillo; Nadim Rayess; David Rein

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1671. doi:

ARVO Annual Meeting Abstract April 2014

Prospective, multicenter determination of visual acuity agreement between the standard Early Treatment of Diabetic Retinopathy Study (ETDRS) chart and a handheld ETDRS equivalent

Ehsan Rahimy; Sahitya Reddy; Francis Char DeCroos; Mohammed Ali Khan; David S Boyer; Omesh P Gupta; Carl D Regillo; Julia A Haller

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1139. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Disease Activity Assessments with Brolucizumab vs Aflibercept in Patients with nAMD in HAWK and HARRIER

Anatomic and visual outcomes of primary retinal detachment in younger adults: a report from the multicenter Primary Retinal Detachment Outcomes (PRO) Study

Retinal Detachment Rates and Clinical Outcomes Following Penetrating and Endothelial Keratoplasty

Characteristics of Clinical Studies Evaluating Off-Label Indications for Novel FDA-Approved Therapeutics in Ophthalmology

Ocular hypertension following intravitreal injection of 0.7mg dexamethasone implant versus 2mg triamcinolone

Clinical outcomes after switch from aflibercept to ranibizumab for macular edema secondary to retinal vein occlusion

Short-Term Outcomes of Eyes with Neovascular Age-related Macular Degeneration (nAMD) that Switched from Aflibercept to Ranibizumab

Incidence of ocular hypertension following intravitreal injection of 2mg triamcinolone

Baseline Choroidal Thickness as a Predictor for Treatment Outcomes in Branch Retinal Vein Occlusion

Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Transplantation for Retinal Degenerations: Three-Year Outcomes Data

Effect of Hydroxychloroquine Exposure and Toxicity on Dark Adaptation

27-gauge vitrectomy wound integrity: a randomized pilot study comparing angled versus straight entry in fluid-filled vitrectomized eyes

Optical Coherence Tomography Angiography in Hydroxychloroquine Toxicity

Comparison of chandelier-assisted scleral buckling versus traditional scleral buckling for rhegmatogenous retinal detachment repair at an academic teaching center

Conversion to aflibercept after prior anti-VEGF therapy for persistent diabetic macular edema

Sustained Delivery of Ranibizumab: The LADDER Trial of the Ranibizumab Port Delivery System

Pharmacologic Closure Rate of Full Thickness Macular Hole with Ocriplasmin—1 year follow-up data

Prospective, Multicenter Investigation of Aflibercept Treat and Extend Therapy for Neovascular Age-related Macular Degeneration (ATLAS Study): One and Two Year Results

Economic Evaluation of Home Telemonitoring for CNV

Prospective, multicenter determination of visual acuity agreement between the standard Early Treatment of Diabetic Retinopathy Study (ETDRS) chart and a handheld ETDRS equivalent

To View More...

You must be signed into an individual account to use this feature.